Barrington Research has recently raised OPKO Health Inc (OPK) stock to Outperform rating, as announced on June 29, 2023, according to Finviz. Earlier, on December 15, 2022, H.C. Wainwright had initiated the stock to Buy, setting a price target of $3. Barrington Research also reduced Mkt Perform rating. Additionally, Ladenburg Thalmann initiated Buy rating on June 21, 2021, with a target price of $7. Piper Jaffray analysts, in their report published on November 25, 2019, also initiated Overweight rating and set a price target of $2.50 for OPKO Health Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
OPKO Health Inc (OPK) Stock Trading Recap
On Monday, OPKO Health Inc (OPK) stock saw a decline, ending the day at $1.48 which represents a decrease of $-0.03 or -1.99% from the prior close of $1.51. The stock opened at $1.5 and touched a low of $1.45 during the day, reaching a high of $1.53. The volume of shares traded was 3.66 million exceeding the average volume of 3.16 million.
Sponsored
OPK Stock Performance and Moving Averages
In recent trading, OPKO Health Inc (OPK) stock price has shown some volatility, fluctuating -1.33% over the last five trades and -0.67% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by 12.12%, and it has gained 10.45% in the previous three months. Currently, OPK is trading at 0.10%, -3.14%, and 13.43% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, OPK, a Healthcare sector stock, is trading -15.19% below its 52-week high but remains 73.79% above its 52-week low. The Average True Range (ATR) (14 days) of 0.07 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
OPKO Health Inc’s Profitability and Valuation Ratios
OPKO Health Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -37.38% and a profit margin of -33.94%, with a gross margin of 12.12%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, OPKO Health Inc’s market capitalization stands at $1.03 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 1.44, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 0.74, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 53.26% of OPKO Health Inc (OPK)’s shares, while financial institutions hold 29.30%.
Notable insider trades include OPKO HEALTH, INC., 10% Owner at OPKO Health Inc (OPK), who sold 50000 shares on Aug 19 ’24, at $34.49 each, totaling $1.72 million. On Aug 16 ’24, OPKO HEALTH, INC., 10% Owner, sold 50000 shares for $34.3 each, amounting to $1.71 million. Additionally, on Aug 15 ’24, OPKO HEALTH, INC. sold 39824 shares at $33.08 each, generating $1.32 million.